References

  1. CBS News. Fountain Of Youth In A Wine Rx? 60 Minutes. [Online] May 21, 2009. [Cited: March 9, 2014.] http://www.cbsnews.com/stories/2009/01/25/60minutes/main4752082.shtml.

  2. Khan, Nasiruddin, et al., et al. Resveratrol and Bioactive Flavonoids in Immune Function. [ed.] Ronald Ross Watson, Sherma Zibadi and Victor R. Preedy. Dietary Components and Immune Function. New York: Springer Science + Business Media, LLC, 2010, 23, pp. 397-420. ISBN: 978-1-60761-060-1.

  3. The Endocrine Society. Red Wine's Resveratrol May Help Battle Obesity. ScienceDaily. [Online] June 17, 2008. [Cited: March 10, 2014.] http://www.sciencedaily.com/releases/2008/06/080616115850.htm.

  4. Survey of the trans-Resveratrol and trans-Piceid Content of Cocoa-Containing and Chocolate Products. Jeffrey Hurst, W., et al., et al.. [ed.] James N. Seiber. 18, Davis: ACS Publications, August 30, 2008, Journal of Agricultural and Food Chemistry, Vol. 56, pp. 8374-8378. DOI: 10.1021/jf801297w; http://pubs.acs.org/doi/abs/10.1021/jf801297w. ISSN: 0021-8561.

  5. Pervaiz, Shazib. Resveratrol: The Promise Therein. [ed.] Lester Packer, Choon Nam Ong and Barry Halliwell. Herbal and Traditional Medicine. New York: Marcel Dekker, 2004, 22. ISBN: 0-8247-5436-0.

  6. Synthesis of Resveratrol and its Derivatives. Takaoka, Michio. 8, s.l.: The Japan Academy, October 12, 1940, Proceedings of the Imperial Academy, Vol. 16, pp. 406-407. ISSN: 0369-9846.

  7. Raul, Francis. Resveratrol as an Antitumor Agent In Vivo. [ed.] Bharat B. Aggarwal and Shishir Shishodia. Resveratrol in Health and Disease. Boca Raton: CRC Press, 2006, 14, pp. 385-398. ISBN: 978-0-8493-3371-2.

  8. Fuller, Bryan B. Antioxidants and anti-inflammatories. [ed.] Zoe Diana Draelos. Cosmetic Dermatology: Products and Procedures. West Sussex: Blackwell Publishing Ltd, 2010, 35, pp. 281-292. ISBN: 978-1-4051-8635-3.

  9. Oregon State University. Oxidative Stress Is Underlying Cause Of Huge Numbers Of Genetic Mutations, Study Finds. ScienceDaily LLC. [Online] September 7, 2009. [Cited: March 10, 2014.] http://www.sciencedaily.com/releases/2009/09/090907162318.htm.

  10. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Dugas, B., et al., et al. [ed.] Gerhard Rechkemmer. 7, Karlsruhe: Springer-Verlag, October 1, 2010, European Journal of Nutrition, Vol. 49, pp. 435-446. DOI: 10.1007/s00394-010-0102-2; http://link.springer.com/article/10.1007%2Fs00394-010-0102-2. ISSN: 1436-6207.

  11. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat. Fukuhara, Shinichiro, et al., et al. [ed.] Irwin Goldstein. 4, San Diego: John Wiley & Sons, Inc.: International Society for Sexual Medicine, April 2011, The Journal of Sexual Medicine, Vol. 8, pp. 1061-1071. DOI: 10.1111/j.1743-6109.2010.02193.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2010.02193.x/abstract. eISSN: 1743-6109.

  12. Skin photoprotection by natural polyphenols: Anti-inflammatory, anti-oxidant and DNA repair mechanisms. Nichols, Joi A. and Katiyar, Santosh K. [ed.] Ulrich Mrowietz. 2, Kiel: Springer-Verlag, March 2010, Archives of Dermatological Research, Vol. 302, pp. 71-83. DOI: 10.1007/s00403-009-1001-3; http://link.springer.com/article/10.1007%2Fs00403-009-1001-3. ISSN: 0340-3696.

  13. Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Jiang, Tao, et al., et al. [ed.] Michael P. Waalkes. 1, s.l.: Elsevier Inc., October 1, 2009, Toxicology and Applied Pharmacology, Vol. 240, pp. 8-14. DOI: 10.1016/j.taap.2009.06.010; http://www.sciencedirect.com/science/article/pii/S0041008X09002580. ISSN: 0041-008X.

  14. Wellcome Trust. Antioxidants Are Unlikely To Prevent Aging, Study Suggests. ScienceDaily LLC. [Online] December 2, 2008. [Cited: March 9, 2014.] http://www.sciencedaily.com/releases/2008/12/081201105711.htm.

  15. Maroon, Joseph. The Longevity Factor. New York: Atria Books, a division of Simon & Schuster, Inc., 2009. ISBN: 978-1-4165-5107-2.

  16. Thomas Jefferson University. Genetic Evidence That Antioxidants Can Help Treat Cancer. ScienceDaily LLC. [Online] February 15, 2011. [Cited: March 9, 2014.] http://www.sciencedaily.com/releases/2011/02/110215102836.htm.

  17. A clinical study evaluating the dermatologic benefits of topical bakuchiol (UP256) cream on facial acne. Shalita, Alan R., et al., et al. 2, New York: Mosby-Elsevier, February 2, 2011, The Journal of the American Academy of Dermatology, Vol. 64, pp. AB19-AB19. ISSN: 0190-9622.

  18. Review: Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Saiko, Philipp, et al., et al. [ed.] M.D. Waters and D.M. DeMarini. 1-2, Research Triangle Park: Elsevier B.V, January-February 2008, Mutation Research/Reviews in Mutation Research, Vol. 658, pp. 68-94. DOI: 10.1016/j.mrrev.2007.08.004; http://www.sciencedirect.com/science/article/pii/S1383574207000324. ISSN: 1383-5742.

  19. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Palsamya, P. and Subramanian, S. [ed.] H. Tapiero, K.D. Tew and D. Machover. 9, s.l.: Elsevier Masson SAS, November 2008, Biomedicine & Pharmacotherapy, Vol. 62, pp. 598-605. DOI: 10.1016/j.biopha.2008.06.037; http://www.sciencedirect.com/science/article/pii/S0753332208001649. ISSN: 0753-3322.

  20. Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer Pain. Tong, Zhiqian, et al., et al. [ed.] Hiroaki Matsunami. 4, Durham: Public Library of Science, April 21, 2010, PLoS ONE, Vol. 5, p. e10234. DOI: 10.1371/journal.pone.0010234; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010234. ISSN: 1932-6203.

  21. Plant Polyphenols as Dietary Antioxidants in Human Health and Disease. Pandey, Kanti Bhooshan and Rizvi, Syed Ibrahim. [ed.] Kenneth Maiese. 5, New York; Cairo: Hindawi Publishing Corporation, Nov-Dec 2009, Oxidative Medicine and Cellular Longevity, Vol. 2, pp. 270-278. DOI: 10.4161/oxim.2.5.9498; http://www.hindawi.com/journals/omcl/2009/897484/abs/. ISSN: 1942-0900.

  22. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 napththalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and biochemical changes. Sharma, Shyam S., et al., et al. [ed.] Michael Davies and Helmut Sies. 4, Sydney: Informa Plc., 2009, Free Radical Research, Vol. 43, pp. 400-408. DOI: 10.1080/10715760902801509; http://informahealthcare.com/doi/abs/10.1080/10715760902801509. ISSN: 1071-5762.

  23. Effect of palmitoylethanolamide–polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations. Ugo Indraccoloab and Fabrizio Barbierib. [ed.] J.O. Drife. 1, Leeds: Elsevier Inc., May 2010, European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 150, pp. 76-79. DOI: 10.1016/j.ejogrb.2010.01.008; http://www.ejog.org/article/S0301-2115(10)00042-4/abstract. ISSN: 0301-2115..

  24. Mullin, Gerard E., Munsell, Melissa and Davison, Ashwini. The Role of Nutrition in Inflammatory Bowel Disease: Food for Thought. [ed.] Bhaskar Banerjee. Nutritional Management of Digestive Disorders. Boca Raton: CRC Press, 2010, 8, pp. 125-148. ISBN: 978-1-4200-8654-6.

  25. Higdon, Jane, Drake, Victoria J. and Steward, William P. Linus Pauling Institute Micronutrient Information Center: Resveratrol. Oregon State University. [Online] May 2008. [Cited: March 10, 2014.] http://lpi.oregonstate.edu/infocenter/phytochemicals/resveratrol/.

  26. Resveratrol in prevention and treatment of common clinical conditions of aging. Markus, M. Andrea and Morris, Brian J. [ed.] Richard F. Walker. 2, s.l.: Dove Medical Press Ltd., June 2008, Clinical Interventions in Aging, Vol. 3, pp. 331-339. eISSN: 1178-1998.

  27. The phytochemical composition and antioxidant actions of tree nuts. Bolling, Bradley W., McKay, Diane L. and Blumberg, Jeffrey B. 1, Clayton: HEC Press: National Health Research Institutes, March 2010, Asia Pacific Journal of Clinical Nutrition, Vol. 19, pp. 117-123. eISSN: 1440-6047.

  28. Howard, Hilary. Fashion & Style: Skin Deep Beauty Spots. The New York Times. [Online] April 13, 2011. [Cited: March 10, 2014.] http://www.nytimes.com/2011/04/14/fashion/14SPOTS.html?_r=1&ref=resveratrol.

  29. Bone, Kerry. e-Monitor No. 34: Studies Provide Insights into Effective Clinical Dose of Resveratrol. Mediherb Clinical Monitor. [Online] November 2010. [Cited: March 10, 2014.] http://www.mediherb.com.au/articles/e-monitorNo.34Nov10.pdf.

  30. Wade, Nicholas. Yes, Red Wine Holds Answer. Check Dosage. The New York Times. [Online] November 6, 2006. [Cited: March 10, 2014.] http://www.nytimes.com/2006/11/02/science/02drug.html?ref=resveratrol&_r=0.

  31. Center for Drug Evaluation and Research Office of New Drugs. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. U.S. Department of Health and Human Services: Food and Drug Administration. [Online] July 6, 2005. [Cited: June 4, 2015.] http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf. J:\!GUIDANC\5541fnlcln1.doc.

  32. Brown, Victoria Alison, Steward, Will P., Brown, Karen. Leicester Research Archive: Pre Clinical and Clinical Studies of the Effects of Resveratrol, a Phytochemical With Potential Chemopreventive Efficacy. University of Leicester. [Online] March 24, 2010. [Cited: March 10, 2014.] http://hdl.handle.net/2381/8203.

  33. Safety of resveratrol with examples for high purity, trans-resveratrol, resVida. Edwards, J. A., et al., et al. [ed.] Douglas Braaten. New York : John Wiley & Sons, Inc., January 24, 2011, Annals of the New York Academy of Sciences, Vol. 1215, pp. 131-137. DOI: 10.1111/j.1749-6632.2010.05855.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2010.05855.x/full. eISSN: 1749-6632.

  34. Resveratrol enhances UVA-induced DNA damage in HaCaT human keratinocytes. Seve, M., et al., et al.Atta-ur-Rahman. 6, Cambridge: Bentham Science, November 1, 2005, Medicinal Chemistry, Vol. 1, pp. 629-633. DOI: 10.2174/157340605774598144; http://www.eurekaselect.com/79781/article. ISSN: 1573-4064.

  35. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Leung, N., et al., et al. [ed.] Qais Al-Awqati. 11, New York: Nature Publishing Group, June 1, 2008, Kidney International, Vol. 73, pp. 1282-1288. DOI: 10.1038/ki.2008.108; http://www.nature.com/ki/journal/v73/n11/full/ki2008108a.html. ISSN: 0085-2538.

  36. Burleson, Katharine. Coronary Artery Disease. [ed.] David Rakel. Integrative Medicine. Second. Philadelphia: Saunders, an imprint of Elsevier Inc., 2007, 28, pp. 295-308. ISBN-13: 978-1-4160-2954-0.

  37. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. Hudson, S.A., et al. [ed.] Richard Perham. 20, Cambridge: John Wiley & Sons, Inc.: Federation of European Biochemical Societies, October 1, 2009, FEBS Journal, Vol. 276, pp. 5960-5972. DOI: 10.1111/j.1742-4658.2009.07307.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1742-4658.2009.07307.x/full. eISSN: 1742-4658.

  38. An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. Nakamura, Mitsuyasu, et al., et al. 2, Beijing: Baishideng Publishing Group Co., Limited, January 14, 2010, World Journal of Gastroenterology, Vol. 16, pp. 184-192. DOI: 10.3748/wjg.v16.i2.184; http://www.wjgnet.com/1007-9327/full/v16/i2/184.htm. ISSN: 1007-9327.

  39. Wade, Nicholas. Drug Doubles Endurance, Study Says. The New York Times Science Section. [Online] November 16, 2006. [Cited: March 28, 2014.] http://www.nytimes.com/2006/11/16/science/17endurancecnd.html.

  40. Sun, Albert Y., et al. Botanical Phenolics and Neurodegeneration. [ed.] Iris F. F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd. Boca Raton: Taylor & Francis Group, LLC: CRC Press, 2011, Vol. Volume 28 of Oxidative Stress and Disease, 15, pp. 315-332. ISBN: 978-1-4398-0713-2.

  41. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Lee, Meeyoung, et al., et al. [ed.] J.E. Talmadge. 4, Omaha: Elsevier B.V., April 2009, International Immunopharmacology, Vol. 9, pp. 418-424. DOI: 10.1016/j.intimp.2009.01.005; http://www.sciencedirect.com/science/article/pii/S1567576909000046. ISSN: 1567-5769.

  42. Chemosensitization of tumors by resveratrol. Gupta, Subash C., et al., et al. [ed.] Douglas Braaten. New York: John Wiley & Sons, Inc., January 24, 2011, Annals of the New York Academy of Sciences, Vol. 1215, pp. 150-160. DOI: 10.1111/j.1749-6632.2010.05852.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2010.05852.x/full. eISSN: 1749-6632.

  43. Resveratrol Impairs the Release of Steroid-Resistant Inflammatory Cytokines from Human Airway Smooth Muscle Cells in Chronic Obstructive Pulmonary Disease. Knobloch, Jürgen, et al., et al. 3, s.l.:The American Society for Pharmacology and Experimental Therapeutics, December 2010, Journal of Pharmacology and Experimental Therapeutics, Vol. 335, pp. 788-798. DOI: 10.1124/jpet.110.166843; http://jpet.aspetjournals.org/content/335/3/788.short. eISSN: 1521-0103.

  44. Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. Dal-Pan, Alexandre; Blanc, Stéphane; Aujard, Fabienne. 11, s.l.:BioMed Central Ltd., June 22, 2010, BMC Physiology, Vol. 10. DOI: 10.1186/1472-6793-10-11; http://www.biomedcentral.com/1472-6793/10/11. ISSN: 1472-6793.

  45. The Effects of Chronic Resveratrol Treatment on Vascular Responsiveness of Streptozotocin-Induced Diabetic Rats. Silan, Coskun. [ed.] Kazuichi Hayakawa. 5, Tokyo: International Academic Printing Co., Ltd.: The Pharmaceutical Society of Japan, May 2008, Biological & Pharmaceutical Bulletin, Vol. 31, pp. 897-902. DOI: 10.1248/bpb.31.897; https://www.jstage.jst.go.jp/article/bpb/31/5/31_5_897/_article. ISSN: 0918-6158.

  46. Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway. Khan, Aslam A., et al., et al. [ed.] Kevin A. Roth. 1, Birmingham : Elsevier Inc.: American Society for Investigative Pathology, July 2010, The American Journal of Pathology, Vol. 177, pp. 481-492. DOI: 10.2353/ajpath.2010.090836; http://ajp.amjpathol.org/article/S0002-9440(10)60103-4/abstract. ISSN: 0002-9440.

  47. Prevention of Ocular Inflammation in Endotoxin-Induced Uveitis with Resveratrol by Inhibiting Oxidative Damage and Nuclear Factor-κB Activation. Kubota, Shunsuke, et al., et al.[ed.] Paul Kaufman. 7, s.l.: Association for Research in Vision and Ophthalmology, July 2009, Investigative Ophthalmology & Visual Science, Vol. 50, pp. 3512-3519. DOI: 10.2353/ajpath.2010.100098; http://www.iovs.org/content/50/7/3512. eISSN: 1552-5783.

  48. Resveratrol Inhibits Neuronal Apoptosis and Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Mouse Retina. Kim, Young-Hee, et al., et al. [ed.] Peter C. Butler. 7, Los Angeles: American Diabetes Association, July 2010, Diabetes, Vol. 59, pp. 1825-1835. DOI: 10.2337/db09-1431; http://diabetes.diabetesjournals.org/content/59/7/1825. ISSN: 0012-1797.

  49. trans-Resveratrol Inhibits Hyperglycemia-Induced Inflammation and Connexin Downregulation in Retinal Pigment Epithelial Cells. Losso, Jack N., Truax, Robert E. and Richard, Gerald. [ed.] James N. Seiber. 14, Davis: American Chemical Society, June 25, 2010, Journal of Agricultural and Food Chemistry, Vol. 58, pp. 8246-8252. DOI: 10.1021/jf1012067; http://pubs.acs.org/doi/abs/10.1021/jf1012067. ISSN: 0021-8561.

  50. Resveratrol Inhibits Pathologic Retinal Neovascularization in Vldlr−/−Mice. Hua, Jing, et al., et al. [ed.] Paul Kaufman. 5, Madison: Association for Research in Vision and Ophthalmology, April 25, 2011, Investigative Ophthalmology & Visual Science, Vol. 52, pp. 2809-2816. DOI: 10.1167/iovs.10-6496; http://www.iovs.org/content/52/5/2809. eISSN: 1552-5783.

  51. Life Extension Update. Resveratrol prevents alcoholic fatty liver disease in mouse model. Life Extension Update. [Online] October 17, 2008. [Cited: March 11, 2014.] http://www.lef.org/newsletter/2008/1017_Resveratrol-Prevents-Alcoholic-Fatty-Liver-Disease-in-Mouse-Model.htm?source=eNewsLetter2009Wk45-2&key=Archive+News.

  52. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Fedson, David S. [ed.] John McConnell. 9, London: Elsevier Limited, September 2008, Lancet Infectious Diseases, Vol. 8, pp. 571-576. DOI: 10.1016/S1473-3099(08)70070-7; http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(08)70070-7/fulltext. ISSN: 1473-3099.

  53. Effects of Resveratrol, a Grape Polyphenol, on Uterine Contraction and Ca2+ Mobilization in Rats in Vivo and in Vitro. Hsia, Shih-Min, Wang, Kai-Lee and Wang, Paulus S. [ed.] Jeffrey D. Blaustein. 5, Boston: The Endocrine Society, May 1, 2011, Endocrinology, Vol. 152, pp. 2090-2099. DOI: 10.1210/en.2010-1223; http://press.endocrine.org/doi/abs/10.1210/en.2010-1223. ISSN: 0013-7227.

  54. Resveratrol supplementation protects against chronic nicotine-induced oxidative damage and organ dysfunction in the rat urogenital system. Toklu, Hale, et al., et al. [ed.] Goksel Sener and Hale Z. Toklu. 1, Istanbul: Marmara University Faculty of Pharmacy, January 2010, Marmara Pharmaceutical Journal, Vol. 14, pp. 29-40. eISSN: 1309-0801.

  55. Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo. Shin, Sunhee, et al., et al. [ed.] Sang-Geon Kim. 1, s.l.: Pharmaceutical Society of Korea, January 1, 2008, Archives of Pharmacal Research, Vol. 31, pp. 83-87. DOI: 10.1007/s12272-008-1124-7; http://link.springer.com/article/10.1007%2Fs12272-008-1124-7. ISSN: 0253-6269.

  56. Resveratrol Attenuates Radiation Damage in Caenorhabditis elegans by Preventing Oxidative Stress. Ye, Kan, et al., et al. [ed.] Yoshiya Furusawa. 4, Chiba: Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology, May 10, 2011, Journal of Radiation Research, Vol. 51, pp. 473-479. DOI: 10.1269/jrr.10009; https://www.jstage.jst.go.jp/article/jrr/51/4/51_10009/_article. ISSN: 1349-9157.

  57. Chemopreventive effects of resveratrol and resveratrol derivatives. Szekeres, Thomas, et al., et al. [ed.] Douglas Braaten. New York: John Wiley & Sons, Inc., January 24, 2011, Annals of the New York Academy of Sciences, Vol. 1215, pp. 89-95. DOI: 10.1111/j.1749-6632.2010.05864.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2010.05864.x/full. eISSN: 1749-6632.

  58. Efficacy study in vitro: assessment of the properties of resveratrol and resveratrol + N-acetyl-cysteine on proliferation and inhibition of collagen activity Giardina, S., et al., et al. 3, s.l.: Edizioni Minerva Medica S.p.A., June 2010, Minerva Ginecologica, Vol. 62, pp. 195-201. ISSN: 0026-4784.

  59. Sirtuins at a glance. Nakagawa, Takashi and Guarente, Leonard. [ed.] Fiona Watt. 6, London: The Company of Biologists Ltd, March 15, 2011, Journal of Cell Science, Vol. 124, pp. 833-838. DOI: 10.1242/jcs.081067; http://jcs.biologists.org/content/124/6/833. ISSN: 0021-9533.

  60. SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. Cao, Cong, et al. [ed.] Laurentiu M. Popescu. 9b, Bucharest: Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd, September 2009, Journal of Cellular and Molecular Medicine, Vol. 13, pp. 3632-3643. DOI: 10.1111/j.1582-4934.2008.00453.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2008.00453.x/full. eISSN: 1582-4934.

  61. Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity. Beher, Dirk, et al., et al. [ed.] Tomi K. Sawyer. 6, Oxford: John Wiley & Sons A/S, December 2009, Chemical Biology & Drug Design, Vol. 74, pp. 619-624. DOI: 10.1111/j.1747-0285.2009.00901.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1747-0285.2009.00901.x/abstract. ISSN: 1747-0277.

  62. Mechanism of Human SIRT1 Activation by Resveratrol. Borra, Margie T., Smith, Brian C. and Denu, John M. [ed.] Herbert Tabor. 17, Bethesda: American Society for Biochemistry and Molecular Biology, April 29, 2005, The Journal of Biological Chemistry, Vol. 280, pp. 17187-17195. DOI: 10.1074/jbc.M501250200; http://www.jbc.org/content/280/17/17187. ISSN: 0021-9258.

  63. The Importance of NAD in Multiple Sclerosis. Penberthy, W. Todd and Tsunoda, Ikuo. [ed.] William A. Banks. 1, Seattle: Bentham Science Publishers, March 5, 2009, Current Pharmaceutical Design, Vol. 15, pp. 64-99. DOI: 10.2174/138161209787185751; http://www.eurekaselect.com/68341/article. ISSN: 1381-6128.

  64. trans-Resveratrol as A Neuroprotectant. Robb, Ellen L. and Stuart, Jeffrey A. [ed.] Derek J. McPhee. 3, Emeryville: MDPI AG, March 3, 2010, Molecules, Vol. 15, pp. 1196-1212. DOI: 10.3390/molecules15031196; http://www.mdpi.com/1420-3049/15/3/1196. ISSN: 1420-3049.

  65. Letter to the Editor: Resveratrol is neuroprotective because it is not a direct activator of Sirt1—A hypothesis. Tang, Bor Luen. [ed.] Andres Buonanno. 4-5, Bethesda : Elsevier Inc., March 16, 2010, Brain Research Bulletin: Letter to the Editor, Vol. 81, pp. 359-361. http://dx.doi.org/10.1016/j.brainresbull.2009.12.007. ISSN: 0361-9230.

  66. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Wong, Aaron K.F., et al., et al. [ed.] R. Clinton Webb. 8, London: Portland Press Ltd: Biochemical Society, March 24, 2010, Clinical Science, Vol. 116, pp. 607-620. DOI: 10.1042/CS20080066; http://www.clinsci.org/cs/116/cs1160607.htm. ISSN: 0143-5221.

  67. Resveratrol Protects Mitochondria against Oxidative Stress through AMP-Activated Protein Kinase-Mediated Glycogen Synthase Kinase-3ß Inhibition Downstream of Poly(ADP-ribose)polymerase-LKB1 Pathway. Shin, Sang Mi, Cho, Il Je and Kim, Sang Geon. [ed.] Jeffrey Conn. 4, Nashville: American Society for Pharmacology and Experimental Therapeutics, October 2009, Molecular Pharmacology, Vol. 76, pp. 884-895. DOI: 10.1124/mol.109.058479; http://molpharm.aspetjournals.org/content/76/4/884. ISSN: 1521-0111.

  68. AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-ß Peptide Metabolism. Vingtdeux, Valérie, et al., et al. [ed.] Herbert Tabor. 12, Bethesda: American Society for Biochemistry and Molecular Biology, March 19, 2010, The Journal of Biological Chemistry, Vol. 285, pp. 9100-9113. DOI: 10.1074/jbc.M109.060061; http://www.jbc.org/content/285/12/9100. ISSN: 0021-9258.

  69. Greene, Alan. Asthma Care Guide: What is asthma? Penn Medicine. [Online] May 16, 2007. [Cited: March 8, 2014.] Philadelphia: The Trustees of the University of Pennsylvania. http://www.pennmedicine.org/health_info/asthma/000159.html.

  70. Rahman, Irfan and Chung, Sangwoon. Dietary Polyphenols, Deacetylases and Chromatin Remodeling in Inflammation. [ed.] Artemis P., Milner, John A. Simopoulos. Personalized Nutrition: Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines. Basel: Karger, 2010, Vol. 101, pp. 84-94. ISBN: 978-3-8055-9427-1.

  71. Steroid Resistance in Pulmonary Diseases. Leung, Donald Y. M. and Searing, Daniel A. [ed.] Steven A. Sahn. Lesson 18, Charleston: American College of Chest Physicians, September 14, 2010, PCCSU, Vol. 24, pp. 1-4

  72. The American Society of Health-System Pharmacists, Inc. Drugs & Supplements: Dexamethasone Oral. MedlinePlus. [Online] September 1, 2010. [Cited: March 12, 2014.] http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682792.html#why.

  73. National Heart Lung and Blood Institute. What Is COPD? U.S. Dept. of Health and Human Services. [Online] July 31, 2013. [Cited: March 12, 2014.] http://www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd_WhatIs.html.

  74. Protective effect of resveratrol against pressure overload-induced heart failure. Gupta, Prakash K., DiPette, Donald J. and Supowit, Scott C. [ed.] Y. Martin Lo. 3, College Park: Wiley Periodicals, Inc., May, 2014, Food Science & Nutrition, Vol. 2, pp. 218-229. DOI: 10.1002/fsn3.92; http://onlinelibrary.wiley.com/doi/10.1002/fsn3.92/full. eISSN: 2048-7177.

  75. The Biological Responses to Resveratrol and Other Polyphenols From Alcoholic Beverages. Brown, Lindsay, et al., et al. [ed.] Harriet de Wit. 9, Chicago: Blackwell Publishing: Research Society on Alcoholism, September 2009, Alcoholism: Clinical and Experimental Research, Vol. 33, pp. 1513-1523. DOI: 10.1111/j.1530-0277.2009.00989.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1530-0277.2009.00989.x/abstract. eISSN: 1530-0277.

  76. Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. Hill, Jonathan M., et al., et al. [ed.] Jeffrey M. Drazen. 7, Boston: Massachusetts Medical Society, February 13, 2003, The New England Journal of Medicine, Vol. 348, pp. 593-600. DOI: 10.1056/NEJMoa022287; http://www.nejm.org/doi/full/10.1056/NEJMoa022287. ISSN: 0028-4793.

  77. Intake of Red Wine Increases the Number and Functional Capacity of Circulating Endothelial Progenitor Cells by Enhancing Nitric Oxide Bioavailability. Huang, Po-Hsun, et al., et al. [ed.] Mark Taubman. 4, Rochester: American Heart Association, Inc., April 2010, Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 30, pp. 869-877. DOI: 10.1161/​ATVBAHA.109.200618; http://atvb.ahajournals.org/content/30/4/869. ISSN: 1079-5642.

  78. Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol. Mukhopadhyay, Partha, et al., et al. [ed.] Piero Anversa. 12, Boston: Public Library of Science, December 23, 2010, PLoS ONE, Vol. 5, p. e15705. DOI: 10.1371/journal.pone.0015705; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015705. ISSN: 1932-6203.

  79. Grape Polyphenols Exert a Cardioprotective Effect in Pre- and Postmenopausal Women by Lowering Plasma Lipids and Reducing Oxidative Stress. Zern, Tosca L., et al., et al. [ed.] A. Catharine Ross. 8, University Park: American Society for Nutrition, August 2005, Journal of Nutrition, Vol. 135, pp. 1911-1917. ISSN: 0022-3166.

  80. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Ohashi, R., et al., et al. 12, s.l.: Oxford University Press: Association of Physicians of Great Britain and Ireland, October 28, 2005, Quarterly Journal of Medicine, Vol. 98, pp. 845-856. DOI: 10.1093/qjmed/hci136; http://qjmed.oxfordjournals.org/content/98/12/845. ISSN: 1460-2725.

  81. Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases. Sun, Albert Y., et al., et al. [ed.] Nicolas G. Bazan. 2-3, New Orleans: Springer Science+Business Media, LLC, June 1, 2010, Molecular Neurobiology, Vol. 41, pp. 375-383. DOI: 10.1007/s12035-010-8111-y; http://link.springer.com/article/10.1007%2Fs12035-010-8111-y. ISSN: 0893-7648.

  82. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Bakker, Gertruud C.M., et al., et al. [ed.] Dennis M. Bier. 4, Houston: American Society for Nutrition, April 2010, American Journal of Clinical Nutrition, Vol. 91, pp. 1044-1059. DOI: 10.3945/ajcn.2009.28822; http://ajcn.nutrition.org/content/91/4/1044. ISSN: 0002-9165.

  83. An Antiinflammatory and Reactive Oxygen Species Suppressive Effects of an Extract of Polygonum Cuspidatum Containing Resveratrol. Ghanim, Husam, et al., et al. [ed.] Leonard Wartofsky. 9, Chevy Chase: The Endocrine Society, September 1, 2010, The Journal of Clinical Endocrinology & Metabolism, Vol. 95, pp. E1-E8. DOI: 10.1210/jc.2010-0482; http://press.endocrine.org/doi/abs/10.1210/jc.2010-0482. ISSN: 0021-972X.

  84. C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians. Windgassen, Elizabeth B., et al., et al. [ed.] Howard A. Miller. 1, Philadelphia: Interstate Postgraduate Medical Association of North America , January 2011, Postgraduate Medicine: Metabolic Disorders, Diabetes, And Cardiovascular Disease, Vol. 123, pp. 114-119. DOI: 10.3810/pgm.2011.01.2252; http://informahealthcare.com/doi/abs/10.3810/pgm.2011.01.2252. ISSN: 0032-5481.

  85. Bowen, R. Pathophysiology of the Endrocrine System: Physiologic Effects of Insulin. Colorado State University Biomedical Hypertextbooks. [Online] August 1, 2009. [Cited: March 14, 2014.] http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/pancreas/insulin_phys.html.

  86. Codario, Ronald A. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. [ed.] Neil S. Skolnik. 2. Philadelphia: Humana Press: Springer Science+Business Media, LLC, 2011. ISBN: 978-1-60327-440-1.

  87. Genetic Science Learning Center. Are Telomeres the Key to Aging and Cancer? The University of Utah: Learn.Genetics. [Online] January 6, 2014. [Cited: March 14, 2014.] http://learn.genetics.utah.edu/content/begin/traits/telomeres/.

  88. Telomerase deficiency impairs glucose metabolism and insulin secretion. Kuhlow, Doreen, et al., et al. [ed.] Mikhail V. Blagosklonny, Judith Campisi and David A. Sinclair. 10, Albany: Impact Journals LLC, October 2010, Aging, Vol. 2, pp. 650-658. eISSN: 1945-4589.

  89. Obesity accelerates thymic aging. Yang, Hyunwon, et al., et al. [ed.] Cynthia E. Dunbar. 8, Bethesda: The American Society of Hematology, October 29, 2009, Blood, Vol. 114, pp. 3803-3812. DOI: 10.1182/blood-2009-03-213595; http://bloodjournal.hematologylibrary.org/content/114/18/3803. ISSN: 0006-4971.

  90. The Impact of Resveratrol on Diet Induced Obesity Changes in Thymic Function. Gulvady, Apeksha A., Ciolino, Henry P. and Jolly, Christopher A. [ed.] T. Scott Lyons and James W. Navalta. 1, Bowling Green; Las Vegas: TopSCHOLAR®, November 18-19, 2010, International Journal of Exercise Science, Vol. 6, p. Article 29. ISSN: 1939-795X.

  91. Kronenberg, Henry M., et al., et al. [ed.] Williams Textbook of Endocrinology. 11. Philadelphia: Saunders, an imprint of Elsevier Inc., 2008. ISBN: 978-1-4160-2911-3.

  92. Sierpina, Victor S. and Udani, Jay. Diabetes. [ed.] David Rakel. Integrative Medicine. 2. Philadelphia: Saunders, an imprint of Elsevier Inc., 2007, 36, pp. 393-408. ISBN-13: 978-1-4160-2954-0.

  93. Obesity and Thyroid Cancer Risk among U.S. Men and Women: A Pooled Analysis of Five Prospective Studies. Kitahara, Cari M., et al., et al. [ed.] Timothy R. Rebbeck. 3, Philadelphia: American Association for Cancer Research, March 2011, Cancer Epidemiology, Biomarkers & Prevention, Vol. 20, pp. 464-472. DOI: 10.1158/1055-9965.EPI-10-1220; http://cebp.aacrjournals.org/content/20/3/464. ISSN: 1055-9965.

  94. Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat. Choudhury, Mahua, Jonscher, Karen R. and Friedman, Jacob E. [ed.] Mikhail V. Blagosklonny, Judith Campisi and David A. Sinclair. 2, Albany: Impact Journals LLC, February 26, 2011, Aging, Vol. 3, pp. 175-178. eISSN: 1945-4589.

  95. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1a. Lagouge, Marie, et al., et al. [ed.] Emilie Marcus. 6, Cambridge: Elsevier Inc., December 15, 2006, Cell, Vol. 127, pp. 1109-1122. DOI: 10.1016/j.cell.2006.11.013; http://www.cell.com/retrieve/pii/S0092867406014280. ISSN: 0092-8674.

  96. Changes in white adipose tissue metabolism induced by resveratrol in rats. Alberdi, Goiuri, et al., et al. [ed.] M. Mahmood Hussain. 29, Brooklyn: BioMed Central Ltd., May 10, 2011, Nutrition & Metabolism, Vol. 8. DOI: 10.1186/1743-7075-8-29; http://www.nutritionandmetabolism.com/content/8/1/29. eISSN: 1743-7075.

  97. Ehrlich, Steven D. Lipase.University of Maryland Medical Center. [Online] May 7, 2013. [Cited: March 15, 2014.] http://www.umm.edu/altmed/articles/lipase-000311.htm.

  98. Effect of resveratrol on fat mobilization. Baile, Clifton A., et al., et al. [ed.] Douglas Braaten. New York : John Wiley & Sons, Inc., January 24, 2011, Annals of the New York Academy of Sciences, Vol. 1215, pp. 40-47. DOI: 10.1111/j.1749-6632.2010.05845.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2010.05845.x/abstract. eISSN: 1749-6632.

  99. Resveratrol, obesity and diabetes. Szkudelska, Katarzyna and Szkudelski, Tomasz. [ed.] F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., June 10, 2010, European Journal of Pharmacology, Vol. 635, pp. 1-8. DOI: 10.1016/j.ejphar.2010.02.054; http://www.sciencedirect.com/science/article/pii/S0014299910002001. ISSN: 0014-2999.

  100. Resveratrol improves health and survival of mice on a high-calorie diet. Baur, Joseph A., et al., et al. [ed.] Philip Campbell. 7117, London: Nature Publishing Group, November 16, 2006, Nature, Vol. 444, pp. 337-342. DOI: 10.1038/nature05354; http://www.nature.com/nature/journal/v444/n7117/full/nature05354.html. ISSN: 0028-0836..

  101. Gajda, Angela M. High Fat Diets for Diet-Induced Obesity Models. New Brunswick: Research Diets, Inc., 2008. Product Literature. Obesity-3000-2-09.

  102. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Rivera, Leonor, et al., et al. [ed.] S.J. Enna. 6, Kansas City: Elsevier B.V., March 15, 2009, Biochemical Pharmacology, Vol. 77, pp. 1053-1063. DOI: 10.1016/j.bcp.2008.11.027; http://www.sciencedirect.com/science/article/pii/S0006295208008605. ISSN: 0006-2952.

  103. WebMD Healthwise. Diabetic Nephropathy - Topic Overview. WebMD: Diabetes Health Center. [Online] January 17, 2013. [Cited: March 29, 2014.] http://diabetes.webmd.com/tc/diabetic-nephropathy-topic-overview.

  104. Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol. Gan, Lu, et al., et al. [ed.] Kazuyuki Shimada. 7, Tochigi: Nature Publishing Group: The Japanese Society of Hypertension, July Masatsugu Horiuchi, 2009, Hypertension Research, Vol. 32, pp. 542-547. DOI: 10.1038/hr.2009.67; http://www.nature.com/hr/journal/v32/n7/full/hr200967a.html. ISSN: 0916-9636.

  105. Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. Huang, Jiung-Pang, et al., et al. [ed.] Kelvin J.A. Davies. 11, Los Angeles: Elsevier Inc, December 1, 2010, Free Radical Biology and Medicine, Vol. 49, pp. 1710-1721. DOI: 10.1016/j.freeradbiomed.2010.08.032; http://www.sciencedirect.com/science/article/pii/S0891584910005319. ISSN: 0891-5849.

  106. Ischemic reperfusion injury of the heart. Pinto, Duane S. and Gibson, C. Michael. [ed.] Morton Arnsdorf. Chicago: Wolters Kluwer Health, October 3, 2013, UpToDate®. ISSN: 1090-3496.

  107. Ramiro-Puig, Emma, et al., et al. Food Antioxidants and Alzheimer's Disease. [ed.] Lester Packer, et al., et al.Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 4, pp. 41-50. ISBN: 978-1-4200-7351-5.

  108. National Institute on Aging. Supporting the Gold Standard: AD Clinical Trials. Alzheimer's Disease Education and Referral Center. Bethesda: U.S. Department of Health and Human Services, 2008. pp. 30-36, 2008 Progress Report on Alzheimer's Disease.

  109. —. A Brief Primer on Alzheimer's Disease. Alzheimer's Disease Education and Referral Center. Bethesda: U.S. Department of Health and Human Services, 2008. pp. 6-8, 2008. Progress Report on Alzheimer's Disease.

  110. Wimo, Anders and Prince, Martin. World Alzheimer Report 2010: The Global Economic Impact of Dementia. Alzheimer's Disease International. [Online] September 21, 2010. [Cited: March 16, 2014.] http://www.alz.org/documents/national/World_Alzheimer_Report_2010_Summary(1).pdf.

  111. Therapeutic potential of resveratrol in Alzheimer's disease. Vingtdeux, Valérie, et al., et al. [ed.] Timothy Shipley. (Suppl 2):S6, s.l. : BioMed Central Ltd., December 3, 2008, BMC Neuroscience, Vol. 9. DOI: 10.1186/1471-2202-9-S2-S6; http://www.biomedcentral.com/1471-2202/9/S2/S6. eISSN: 1471-2202.

  112. Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus. Harada, Naoaki, et al., et al. [ed.] Bernhard Hennig. 12, Lexington: Elsevier Inc., December 2011, The Journal of Nutritional Biochemistry, Vol. 22, pp. 1150-1159. DOI: 10.1016/j.jnutbio.2010.09.016; http://www.jnutbio.com/article/S0955-2863(10)00245-7/abstract. ISSN: 0955-2863.

  113. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Quincozes-Santos, André and Gottfried, Carmem. [ed.] Douglas Braaten. New York: John Wiley & Sons, Inc., January 24, 2011, Annals of the New York Academy of Sciences, Vol. 1215, pp. 72-78. DOI: 10.1111/j.1749-6632.2010.05857.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2010.05857.x/full. eISSN: 1749-6632.

  114. Clinical trials of resveratrol. Patel, Ketan R., et al., et al. [ed.] Douglas Braaten. New York: John Wiley & Sons, Inc., January 24, 2011, Annals of the New York Academy of Sciences, Vol. 1215, pp. 161-169. DOI: 10.1111/j.1749-6632.2010.05853.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2010.05853.x/full. eISSN: 1749-6632.

  115. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Schmatza, Roberta, et al., et al. [ed.] W.H. Gispen and F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., May 21, 2009, European Journal of Pharmacology, Vol. 610, pp. 42-48. DOI: 10.1016/j.ejphar.2009.03.032; http://www.sciencedirect.com/science/article/pii/S0014299909002489. ISSN: 0014-2999.

  116. Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of A² oligomers. De Felice, Fernanda G., et al., et al. [ed.] Joseph S. Takahashi. 18, Evanston: National Academy of Sciences of the United States of America, February 10, 2009, PNAS, Vol. 106, pp. 1971-1976. DOI: 10.1073/pnas.0809158106; http://www.pnas.org/content/106/6/1971.full. eISSN: 1091-6490.

  117. The Michael J. Fox Foundation for Parkinson's Research. Parkinson's Diagnostic Questions. The Michael J. Fox Foundation for Parkinson's Research. [Online] [Cited: March 16, 2014.] http://www.michaeljfox.org/living_aboutParkinsons_parkinsons101.cfm#q10.

  118. Becker, Julia, Castillo, Kelsey and Fraley, Gregory. Resveratrol Ameliorates Brain Damage Induced By Surgical Cannulae: Potential For Treatment Of Parkinson's Disease. Hope College. [Online] April 15, 2011. [Cited: March 16, 2014.] http://digitalcommons.hope.edu/curcp_10/191/.

  119. Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Bournival, J., Quessy, P., Martinoli, M.G. [ed.] Juan M. Saavedra. 8, Washington, DC: Springer US, December 1, 2009, Cellular and Molecular Neurobiology, Vol. 29, pp. 1169-1180. DOI: 10.1007/s10571-009-9411-5; http://link.springer.com/article/10.1007%2Fs10571-009-9411-5. ISSN: 0272-4340.

  120. Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice. Anandhan, Annadurai, et al., et al. [ed.] Akshay Anand. 3, Chandigarh: Indian Academy of Neurosciences, July 2010, Annals of Neurosciences, Vol. 17. DOI: 10.5214/ans.0972-7531.1017304; http://annalsofneurosciences.org/journal/index.php/annal/article/view/238. eISSN: 0976-3260.

  121. Analysis of candidate genes for macular telangiectasia type 2. Parmalee, Nancy L., et al., et al. [ed.] Jeffrey Boatright. Atlanta: Emory University, December 14, 2010, Molecular Vision, Vol. 16, pp. 2718-2726. ISSN: 1090-0535.

  122. Nutrition as a Mediator of Visual Health Across the Lifespan. Renzi, Lisa M. and Hammond, Billy R. [ed.] Klaus Kraemer. 3, Basel: Royal DSM, 2010, Sight and Life, Vol. 2, pp. 2-11. ISBN: 978-3-906412-62-7.

  123. Familial Asymptomatic Macular Telangiectasia Type 2. Gillies, Mark C., et al., et al. [ed.] George B. Bartley. 12, Rochester: Elsevier Inc., December 28, 2009, Ophthalmology, Vol. 116, pp. 2422-2429. DOI: 10.1016/j.ophtha.2009.05.010; http://www.aaojournal.org/article/S0161-6420(09)00521-1/abstract. ISSN: 0161-6420.

  124. National Eye Institute. Facts About Age-Related Macular Degeneration. U.S. Department of Health and Human Services. [Online] July 2013. [Cited: June 2, 2015.] http://www.nei.nih.gov/health/maculardegen/armd_facts.

  125. Resveratrol Prevents Light-Induced Retinal Degeneration via Suppressing Activator Protein-1 Activation. Kubota, Shunsuke, et al., et al. [ed.] Michael P. Lisanti. 4, Philadelphia: American Society for Investigative Pathology, October 2010, The American Journal of Pathology, Vol. 177, pp. 1725-1731. DOI: 10.2353/ajpath.2010.100098; http://ajp.amjpathol.org/article/S0002-9440(10)60225-8/abstract. ISSN: 0002-9440.

  126. Glycated Albumin Induces Activation of Activator Protein-1 in Retinal Glial Cells. Okumura, Akinori, et al., et al. [ed.] Mitsuru Sawa. 3, Tokyo: Springer-Verlag, May 1, 2007, Japanese Journal of Ophthalmology, Vol. 51, pp. 236-237. DOI: 10.1007/s10384-007-0431-8; http://link.springer.com/article/10.1007%2Fs10384-007-0431-8. ISSN: 0021-5155.

  127. Boulton, Michael E., et al., et al. γ-Secretase Regulates VEGFR-1 Signalling in Vascular Endothelium and RPE. [ed.] Matthew M. LaVail, Joe G. Hollyfield and Robert Eugene Anderson. Recent Advances in Retinal Degeneration. New York: Springer Science+Business Media, LLC, 2008, Vol. 613: Advances in Experimental Medicine and Biology, pp. 313-320. ISBN: 978-0-387-7490-0.

  128. Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells. Wang, Hui, et al., et al. [ed.] Sam J. Enna. 9, Kansas City: Elsevier B.V., November 1, 2010, Biochemical Pharmacology, Vol. 80, pp. 1386-1395. DOI: 10.1016/j.bcp.2010.07.034; http://www.sciencedirect.com/science/article/pii/S0006295210005721. ISSN: 0006-2952.

  129. Resveratrol Protects Human Retinal Pigment Epithelial Cells from Acrolein-Induced Damage. Sheu, Shwu-Jiuan, Liu, Ni-Chun and Chen, Jiunn-Liang. [ed.] W. Daniel Stamer. 3, Durham: Mary Ann Liebert, Inc., June 2010, Journal of Ocular Pharmacology and Therapeutics, Vol. 26, pp. 231-236. DOI: 10.1089/jop.2009.0137; http://online.liebertpub.com/doi/abs/10.1089/jop.2009.0137. ISSN: 1080-7683.

  130. Phagocytosis of Retinal Rod and Cone Photoreceptors. Kevany, Brian M. and Palczewski, Krzysztof. [ed.] Walter F. Boron. 1, Cleveland: American Physiological Society, February 1, 2010, Physiology, Vol. 25, pp. 8-15. DOI: 10.1152/physiol.00038.2009; http://physiologyonline.physiology.org/content/25/1/8.full. ISSN: 1548-9213.

  131. Anti-inflammatory therapy for diabetic retinopathy. Zhang, Wenbo, et al., et al. [ed.] Yutaka Kawakami, Francesco M. Marincola and David C. Wraith. 5, Tokyo; Bethesda; Bristol: Future Medicine Ltd, May 2011, Immunotherapy, Vol. 3, pp. 609-628. DOI: 10.2217/imt.11.24; http://www.futuremedicine.com/doi/abs/10.2217/imt.11.24. ISSN: 1750-743X.

  132. National Eye Institute. Facts About Diabetic Retinopathy. U.S. Department of Health and Human Services. [Online] June 2012. [Cited: June 9, 2015.] http://www.nei.nih.gov/health/diabetic/retinopathy.

  133. Comprehensive Review of the Effects of Diabetes on Ocular Health. Skarbez, Kathryn, et al., et al. 4, s.l.: Informa Plc, August 2010, Expert Review of Ophthalmology, Vol. 5, pp. 557-577. DOI: 10.1586/eop.10.44; http://informahealthcare.com/doi/abs/10.1586/eop.10.44. ISSN: 1746-9899.

  134. Hyperglycemia in Streptozotocin-Induced Diabetes Leads to Persistent Inflammation and Tissue Damage Following Uveitis Due to Reduced Levels of Ciliary Body Heme Oxygenase-1. Rossi, Settimio, et al., et al. Article ID 60285, s.l.: Hindawi Publishing Corporation, May 17, 2006, Mediators of Inflammation, Vol. 2006, pp. 1-6. DOI: 10.1155/MI/2006/60285; http://www.hindawi.com/journals/mi/2006/060285/abs/. ISSN: 0962-9351.

  135. Resveratrol, a Component of Red Wine, Elicits Dilation of Isolated Porcine Retinal Arterioles: Role of Nitric Oxide and Potassium Channels. Nagaoka, Taiji, et al., et al. [ed.] Robert N. Frank. 9, Detroit: Association for Research in Vision and Ophthalmology, September 2007, Investigative Ophthalmology & Visual Science, Vol. 48, pp. 4232-4239. DOI: 10.1167/iovs.07-0094; http://www.iovs.org/content/48/9/4232. eISSN: 1552-5783.

  136. Idiopathic Macular Telangiectasia. Yannuzzi, Lawrence A., et al., et al. [ed.] Daniel Albert. 4, Madison: American Medical Association, April 2006, Archives of Ophthalmology, Vol. 124, pp. 450-460. DOI: 10.1001/archopht.124.4.450; http://archopht.jamanetwork.com/article.aspx?articleid=417606. ISSN: 0003-9950.

  137. NF-κB inhibitory action of resveratrol: A probable mechanism of neuroprotection in experimental diabetic neuropathy. Kumara, Ashutosh and Sharma, Shyam S. [ed.] Ernesto Carafoli. 2, Padua: Elsevier Inc., April 2, 2010, Biochemical and Biophysical Research Communications, Vol. 394, pp. 360-365. DOI: 10.1016/j.bbrc.2010.03.014; http://www.sciencedirect.com/science/article/pii/S0006291X10004511. ISSN: 0006-291X.

  138. Mayo Clinic staff. Diabetic neuropathy. Mayo Foundation for Medical Education and Research. [Online] March 2012, 27. [Cited: March 17, 2014.] http://www.mayoclinic.org/diseases-conditions/diabetic-neuropathy/basics/symptoms/con-20033336.

  139. Role of Poly(ADP-Ribose) Polymerase Activation in Diabetic Neuropathy. Obrosova, Irina G., et al., et al. [ed.] Franz M. Matschinsky. 3, Philadelphia: American Diabetes Association, March 2004, Diabetes, Vol. 53, pp. 711-720. DOI: 10.2337/diabetes.53.3.711; http://diabetes.diabetesjournals.org/content/53/3/711. ISSN: 0012-1797.

  140. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Kumar, P., Padi, S.S., Naidu, P.S., Kumar, A. [ed.] Rainer Spanagel. 5-6, s.l.: Lippincott Williams & Wilkins, Inc., September 2006, Behavioural Pharmacology, Vol. 17, pp. 485-492. ISSN: 0955-8810.

  141. Mitochondrial Structural and Functional Dynamics in Huntington's Disease. Reddy, P. Hemachandra, Mao, Peizhong and Manczak, Maria. [ed.] Floyd E. Bloom. 1, La Jolla: Elsevier B.V., June 2009, Brain Research Reviews, Vol. 61, pp. 33-48. DOI: 10.1016/j.brainresrev.2009.04.001; http://www.sciencedirect.com/science/article/pii/S0165017309000381. ISSN: 0006-8993.

  142. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Maher, Pamela, et al., et al. [ed.] Kay Davies, Anthony Wynshaw-Boris and Joel Hirschhorn. 2, Oxford; Cleveland; Boston: Oxford University Press, January 15, 2011, Human Molecular Genetics, Vol. 20, pp. 261-270. DOI: 10.1093/hmg/ddq460; http://hmg.oxfordjournals.org/content/20/2/261. ISSN: 0891-5849.

  143. Mitochondria, Calcium, and Calpain are Key Mediators of Resveratrol-Induced Apoptosis in Breast Cancer. Sareen, Dhruv, et al., et al. [ed.] Jeffrey Conn. 6, Nashville: American Society for Pharmacology and Experimental Therapeutics, December 2007, Molecular Pharmacology, Vol. 72, pp. 1466-1475. DOI: 10.1124/mol.107.039040; http://molpharm.aspetjournals.org/content/72/6/1466. ISSN: 1521-0111.

  144. May Diet and Dietary Supplements Improve the Wellness of Multiple Sclerosis Patients? A Molecular Approach. Riccio, Paolo, Rossano, Rocco and Liuzzi, GraziaMaria. [ed.] Corrado Betterle. Article ID 249842, Padua: SAGE-Hindawi Access to Research, December 27, 2010, Autoimmune Diseases, Vol. 2010, pp. 1-12. DOI: 10.4061/2010/249842; http://www.hindawi.com/journals/ad/2010/249842/. ISSN: 2090-0430.

  145. Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis. Shindler, Kenneth S., et al., et al. [ed.] Lanning B. Kline. 4, Birmingham: Lippincott Williams & Wilkins, Inc., December 2010, Journal of Neuro-Ophthalmology, Vol. 30, pp. 328-339. DOI: 10.1097/WNO.0b013e3181f7f833; http://journals.lww.com/jneuro-ophthalmology/pages/articleviewer.aspx?year=2010&issue=12000&article=00007&type=abstract. eISSN: 1536-5166.

  146. Resveratrol inhibits nonalcoholic fatty liver disease in rats. Bujanda, Luis, et al., et al. [ed.] Melissa Norton. 40, s.l.: BioMed Central Ltd, September 9, 2008, BMC Gastroenterology, Vol. 8. DOI: 10.1186/1471-230X-8-40; http://www.biomedcentral.com/1471-230X/8/40. ISSN: 1471-230X.

  147. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Colak, Yasar, et al., et al. [ed.] George B. Stefano. 5, Old Westbury: International Scientific Information, Inc., May 2, 2011, Medical Science Monitor, Vol. 17, pp. HY5-HY9. DOI: 10.12659/MSM.881749; http://www.medscimonit.com/abstract/index/idArt/881749. ISSN: 1643-3750.

  148. Baek, Seung J. and Whitlock, Nichelle C. Molecular Targets of Resveratrol in Carcinogenesis. [ed.] William C.S. Cho. Evidence-based Anticancer Herbal Medicine. Dordrecht: Springer Science+Business Media B.V., 2011, 15, pp. 319-348. ISBN: 978-94-007-0525-8.

  149. TRAIL in cancer therapy: present and future challenges. Mérino, Delphine, et al., et al. [ed.] Daniele Santini. 10, Rome: Informa Plc, October 2007, Expert Opinion on Therapeutic Targets, Vol. 11, pp. 1299-1314. DOI: 10.1517/14728222.11.10.1299; http://informahealthcare.com/doi/abs/10.1517/14728222.11.10.1299. ISSN: 1472-8222.

  150. Phytochemicals in Cancer Prevention and Therapy: Truth or Dare? Russo, Maria, et al., et al. [ed.] Florian Lang. 4, Basel: Molecular Diversity Preservation International, March 31, 2010, Toxins, Vol. 2, pp. 517-551. DOI: 10.3390/toxins2040517; http://www.mdpi.com/2072-6651/2/4/517. ISSN: 2072-6651.

  151. Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent. Boocock, David J., et al., et al. [ed.] Timothy R. Rebbeck. 6, Philadelphia: American Association for Cancer Research, June 2007, Cancer Epidemiology, Biomarkers & Prevention, Vol. 16, pp. 1246-1252. DOI: 10.1158/1055-9965.EPI-07-0022; http://cebp.aacrjournals.org/content/16/6/1246. ISSN: 1055-9965.

  152. Cellular signaling perturbation by natural products. Sarkar, F.H., et al., et al. [ed.] Miles D. Houslay. 11, Glasgow: Elsevier Inc., November 2009, Cellular Signalling, Vol. 21, pp. 1541-1547. DOI: 10.1016/j.cellsig.2009.03.009; http://www.sciencedirect.com/science/article/pii/S0898656809001120. ISSN: 0898-6568.

  153. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Pan, Min-Hsiung, et al., et al. [ed.] Curtis C. Harris. 7, Bethesda: Oxford University Press, July 2009, Carcinogenesis, Vol. 30, pp. 1234-1242. DOI: 10.1093/carcin/bgp121; http://carcin.oxfordjournals.org/content/30/7/1234.full. ISSN: 0143-3334.

  154. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Hsieh, Tze-Chen and Wu, Joseph M. [ed.] Demetrios A. Spandidos. 4, Athens: Spandidos Publications, October 2008, International Journal of Oncology, Vol. 33, pp. 851-859. DOI: 10.3892/ijo_00000073; http://www.spandidos-publications.com/ijo/33/4/851/abstract. ISSN: 1019-6439.

  155. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Bai, Yu, et al., et al. [ed.] Yusuke Nakamura. 2, Chicago: John Wiley & Sons, Inc.: Japanese Cancer Association, February 2010, Cancer Science, Vol. 101, pp. 488-493. DOI: 10.1111/j.1349-7006.2009.01415.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2009.01415.x/full. eISSN: 1349-7006.

  156. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. Gatouillat, Grégory, et al., et al. [ed.] C. Fred Fox, Gary S. Stein and Max M. Burger. 4, Los Angeles; Burlington; Basel: Wiley-Liss, Inc., July 1, 2010, Journal of Cellular Biochemistry, Vol. 110, pp. 893-902. DOI: 10.1002/jcb.22601; http://onlinelibrary.wiley.com/doi/10.1002/jcb.22601/full. eISSN: 1097-4644.

  157. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Wang, Thomas T. Y., et al. [ed.] Hans-Ulrich Humpf. 3, Münster: WILEY-VCH Verlag GmbH & Co., March 2010, Molecular Nutrition & Food Research, Vol. 54, pp. 335-344. DOI: 10.1002/mnfr.200900143; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.200900143/abstract. ISSN: 1613-4125.

  158. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Athar, Mohammad, et al., et al. 2, s.l.: Elsevier Inc., June 15, 2009, Archives of Biochemistry and Biophysics, Vol. 486, pp. 95-102. DOI: 10.1016/j.abb.2009.01.018; http://www.sciencedirect.com/science/article/pii/S0003986109000216. ISSN: 0003-9861.

  159. 2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules. Lia, Haitao, et al., et al. [ed.] Sam J. Enna. 9, Kansas City: Elsevier B.V., November 1, 2009, Biochemical Pharmacology, Vol. 78, pp. 1224-1232. DOI: 10.1016/j.bcp.2009.06.109; http://www.sciencedirect.com/science/article/pii/S000629520900598X. ISSN: 0006-2952.

  160. National Cancer Institute. NCI Dictionary of Cancer Terms: Liposomal. Cancer.gov. [Online] [Cited: March 18, 2014.] http://www.cancer.gov/dictionary/?CdrID=45753.

  161. Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines. Mao, Qi-Qi, et al., et al. [ed.] Peter Schreier. 11, Wuerzburg : WILEY-VCH Verlag GmbH & Co. KGaA, November 2010, Molecular Nutrition & Food Research, Vol. 54, pp. 1574-1584. DOI: 10.1002/mnfr.200900392; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.200900392/abstract. ISSN: 1613-4133.

  162. Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen Efficacy. Lubet, Ronald A., et al., et al. [ed.] William D. Steers. 4, Charlottesville: Elsevier Inc., April 2010, The Journal of Urology, Vol. 183, pp. 1598-1603. DOI: 10.1016/j.juro.2009.12.001; http://www.jurology.com/article/S0022-5347(09)03145-0/abstract. ISSN: 0022-5347.

  163. Hoekstra, Anna and Rodriguez, Gustavo C. Chemoprevention of Ovarian Cancer. [ed.] M. Sharon Stack, David A. Fishman and Stephen T. Rosen. Ovarian Cancer. 2nd. New York: Springer Science+Business Media, LLC, 2009, 1, pp. 3-34. ISBN: 978-0-387-98094-2.

  164. Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target. Mee-Hyun, Lee, et al., et al. [ed.] Frank J. Rauscher III. 18, Philadelphia: American Association for Cancer Research, September 15, 2009, Cancer Research, Vol. 69, pp. 7449-7458. DOI: 10.1158/0008-5472.CAN-09-1266; http://cancerres.aacrjournals.org/content/69/18/7449. ISSN: 0008-5472.

  165. Resveratrol-induced Autophagocytosis in Ovarian Cancer Cells. Opipari, A.W. Jr., et al., et al. [ed.] Frank J. Rauscher III. 2, Philadelphia: American Association for Cancer Research, January 15, 2004, Cancer Research, Vol. 64, pp. 696-703. DOI: 10.1158/0008-5472.CAN-03-2404; http://cancerres.aacrjournals.org/content/64/2/696.long. ISSN: 1940-6207.

  166. Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies. Mimeault, Murielle and Batra, Surinder K. [ed.] Laurentiu M. Popescu. 1-2, Bucharest: Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd, January 2010, Journal of Cellular and Molecular Medicine, Vol. 14, pp. 116-134. DOI: 10.1111/j.1582-4934.2009.00885.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2009.00885.x/abstract. eISSN: 1582-4934.

  167. Ultraviolet Light Induced Alteration to the Skin. Svobodova, Alena, Walterova, Daniela and Vostalova, Jitka. [ed.] Jitka Ulrichová and Vilím Šimánek. 1, Olomouc: Palacký University, Faculty of Medicine and Dentistry, 2006, Biomedical Papers, Vol. 150, pp. 25-38. ISSN: 1213-8118.

  168. Botanicals for the prevention and treatment of cutaneous melanoma. Syed, Deeba N. and Mukhtar, Hasan. [ed.] Ze'ev Ronai. 4, La Jolla: John Wiley & Sons A/S, August 2011, Pigment Cell & Melanoma Research, Vol. 24, pp. 688-702. DOI: 10.1111/j.1755-148X.2011.00851.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2011.00851.x/full. eISSN: 1755-148X.

  169. Resveratrol Inhibits Uveal Melanoma Tumor Growth via Early Mitochondrial Dysfunction. Ginkel, Paul R. van, et al., et al. [ed.] Paul L. Kaufman. 4, Madison: Association for Research in Vision and Ophthalmology, April 2008, Investigative Ophthalmology & Visual Science, Vol. 49, pp. 1299-1306. DOI: 10.1167/iovs.07-1233; http://www.iovs.org/content/49/4/1299.full. eISSN: 1552-5783.

  170. Biological Sensors for Solar Ultraviolet Radiation. Yagura, Teiti, et al., et al. [ed.] W. Rudolf Seitz. 4, Durham: MDPI Publishing, April 12, 2011, Sensors, Vol. 11, pp. 4277-4294. DOI: 10.3390/s110404277; http://www.mdpi.com/1424-8220/11/4/4277. ISSN: 1424-8220.

  171. Resveratrol protects against irradiation-induced hepatic and ileal damage via its anti-oxidative activity. Veliolu-Oünç, A., Sehirli, O., Toklu, H.Z., Ozyurt, H., Mayadali, A., Ek_iolu-Demiralp, E., Erzik, C., Cetinel, S., Yeen, B.C., Sener, G. [ed.] Michael Davies and Helmut Sies. 11, Sydney: Informa Plc, 2009, Free Radical Research, Vol. 43, pp. 1060-1071. DOI: 10.1080/10715760903171100; http://informahealthcare.com/doi/abs/10.1080/10715760903171100. ISSN: 1071-5762.

  172. Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression. Liu, Yong, et al., et al. [ed.] F.P. Nijkamp. 1, Utrecht: Elsevier B.V., January 10, 2011, European Journal of Pharmacology, Vol. 650, pp. 130-137. DOI: 10.1016/j.ejphar.2010.10.009; http://www.sciencedirect.com/science/article/pii/S0014299910010125. ISSN: 0014-2999.

  173. Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells. Chen, Ming-liang, et al., et al. 5, October 2006, Journal of Central South University (Medical Sciences), Vol. 31, pp. 635-639. ISSN: 1672-7347.

  174. University of Texas Health Science Center at San Antonio. Step Toward a New Sunscreen? Plant Agents Show Promise in Preventing Skin Cancer. ScienceDaily. [Online] August 31, 2010. [Cited: March 25, 2014.] http://www.sciencedaily.com/releases/2010/08/100827092830.htm.

  175. Resveratrol as an Inhibitor of Carcinogenesis. Pezzuto, John M. 7-8, West Lafayette: Informa Healthcare USA, Inc., April 7, 2008, Pharmaceutical Biology, Vol. 46, pp. 443-573. DOI: 10.1080/13880200802116610; http://informahealthcare.com/doi/abs/10.1080/13880200802116610. ISSN: 1388-0209.

  176. Protective Action of Resveratrol in Human Skin: Possible Involvement of Specific Receptor Binding Sites. Bastianetto, Stéphane, et al., et al. [ed.] Maria A. Deli. 9, Budapest: Public Library of Science, September 23, 2010, PLoS ONE, Vol. 5, p. e12935. DOI: 10.1371/journal.pone.0012935; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0012935. ISSN: 1932-6203.

  177. Holzer, Aton M., et al., et al. Systemic and Topical Use of Green Tea Polyphenols for Healthy Skin. [ed.] Jean Krutmann and Philippe Humbert. Nutrition for Healthy Skin: Strategies for Clinical and Cosmetic Practice. Berlin: Springer-Verlag Berlin Heidelberg, 2011, 7, pp. 71-85. ISBN: 978-3-642-12263-7.

  178. Kundu, Joydeb K. and Surh, Young-Joon. Resveratrol: The Biochemistry Behind Its Anticancer Effects. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 15, pp. 331-360. ISBN: 978-0-470-28721-7.

  179. Rundhaug, Joyce E. and Fischer, Susan M. Cyclooxygenase-2 Signaling in Squamous Cell Carcinomas. [ed.] Adam B. Glick and Carter Van Waes. Signaling Pathways in Squamous Cancer. New York: Springer Science+Business Media, LLC, 2011, 6, pp. 131-148. ISBN: 978-1-4419-7202-6.

  180. Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Yusuf, Nabiha, et al., et al. 8, s.l.: Wiley-Liss, Inc., August 2009, Molecular Carcinogenesis, Vol. 48, pp. 713-723. DOI: 10.1002/mc.20517; http://onlinelibrary.wiley.com/doi/10.1002/mc.20517/abstract. eISSN: 1098-2744.

  181. Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-κB pathway in human epidermoid carcinoma A431 cells. Roy, Preeti, et al., et al. [ed.] William J. Lennarz. 2, Stony Brook: Elsevier Inc., June 26, 2009, Biochemical and Biophysical Research Communications, Vol. 384, pp. 215-220. DOI: 10.1016/j.bbrc.2009.04.100; http://www.sciencedirect.com/science/article/pii/S0006291X09008109. ISSN: 0006-291X.

  182. Damian, Diona L. and Halliday, Gary M. Photoprotection by Nicotinamide. [ed.] Jean Krutmann and Philippe Humbert. Nutrition for Healthy Skin: Strategies for Clinical and Cosmetic Practice. Berlin: Springer-Verlag Berlin Heidelberg, 2011, 11, pp. 119-128. ISBN: 978-3-642-12263-7.

  183. Afaq, Farrukh and Mukhtar, Hasan. Botanical Antioxidants for Skin Protection: An Overview. [ed.] Jean Krutmann and Philippe Humbert. Nutrition for Healthy Skin: Strategies for Clinical and Cosmetic Practice. Berlin: Springer-Verlag Berlin Heidelberg, 2011, 5, pp. 51-64. ISBN: 978-3-642-12263-7.

  184. Resveratrol Modulates Tumor Cell Proliferation and Protein Translation via SIRT1-Dependent AMPK Activation. Lin, Jia-Ni, et al., et al. [ed.] James N. Seiber. 3, Davis: American Chemical Society, February 10, 2010, Journal of Agricultural and Food Chemistry, Vol. 58, pp. 1584-1592. DOI: 10.1021/jf9035782; http://pubs.acs.org/doi/abs/10.1021/jf9035782. ISSN: 0021-8561.

  185. The significance of Nrf2 pathway in (photo)-oxidative stress response in melanocytes and keratinocytes of the human epidermis. Marrot, Laurent, et al., et al. [ed.] Ze'ev Ronai. 1, La Jolla: John Wiley & Sons A/S, February 2008, Pigment Cell & Melanoma Research, Vol. 21, pp. 79-88. DOI: 10.1111/j.1755-148X.2007.00424.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2007.00424.x/abstract. eISSN: 1755-148X.

  186. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Muñoz, Purificación, et al., et al. [ed.] Philip Campbell. 10, Basingstoke: Nature Publishing Group, October 2005, Nature Genetics, Vol. 37, pp. 1063-1071. DOI: 10.1038/ng1633; http://www.nature.com/ng/journal/v37/n10/full/ng1633.html. ISSN: 1061-4036.

  187. Krutmann, Jean. Skin Aging. [ed.] Jean Krutmann and Philippe Humbert. Nutrition for Healthy Skin: Strategies for Clinical and Cosmetic Practice. Berlin: Springer-Verlag Berlin Heidelberg, 2011, 2, pp. 15-24. ISBN: 978-3-642-12263-7.

  188. Molecular targets of dietary agents for prevention and therapy of cancer. Aggarwal, Bharat B. and Shishodia, Shishir. [ed.] Sam J. Enna. 10, Kansas City: Elsevier Inc., May 14, 2006, Biochemical Pharmacology, Vol. 71, pp. 1397-1421. DOI: 10.1016/j.bcp.2006.02.009; http://www.sciencedirect.com/science/article/pii/S0006295206000955. ISSN: 0006-2952.

  189. Baumann, Leslie and Allemann, Inja Bogdan. Antioxidants. [ed.] Leslie Baumann, Sogol Saghari and Edmund Weiserg. Cosmetic Dermatology Principles and Practice. 2nd. New York: The McGraw-Hill Companies, Inc., 2209, 34, pp. 292-311. ISBN: 978-0-07-164128-9.

  190. Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Bhattacharya, Saswatia, Darjatmoko, Soesiawati, Polans, Arthur S. [ed.] Ferdy J. Lejeune and Walter J. Storkus. 3, Lausanne; Pittsburgh: Lippincott Williams & Wilkins, Inc., June 2011, Melanoma Research, Vol. 21, pp. 180-187. DOI: 10.1097/CMR.0b013e3283456dfc; http://journals.lww.com/melanomaresearch/pages/articleviewer.aspx?year=2011&issue=06000&article=00003&type=abstract. ISSN: 0960-8931.

  191. DiChiara, Timothy. Cancer Chemotherapy for Melanoma: Dacarbazine. About.com Skin Cancer. [Online] May 5, 2009. [Cited: March 26, 2014.] http://skincancer.about.com/od/treatmentoptions/a/melanoma_chemo.htm.

  192. Pruthi, Sandhya. Diseases and Conditions: HER2-positive breast cancer: What is it? Mayo Foundation for Medical Education and Research. [Online] February 20, 2010. [[Cited: March 26, 2014.] Mayo Foundation for Medical Education and Research. http://www.mayoclinic.com/health/breast-cancer/AN00495.

  193. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Lu, Fang, et al., et al. [ed.] Scott M. Lippman. 2, Philadelphia: American Association for Cancer Research, July 2008, Cancer Prevention Research, Vol. 1, pp. 135-145. DOI: 10.1158/1940-6207.CAPR-08-0037; http://cancerpreventionresearch.aacrjournals.org/content/1/2/135/long. ISSN: 1940-6207.

  194. Resveratrol Induces Growth Inhibition, S-phase Arrest, Apoptosis, and Changes in Biomarker Expression in Several Human Cancer Cell Lines. Joe, Andrew K., et al., et al. [ed.] John Mendelsohn. 3, Houston: American Association for Cancer Research, March 1, 2002, Clinical Cancer Research, Vol. 8, pp. 893-903. ISSN: 1078-0432.

  195. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis. Wang, Rui-Hong, et al., et al. 1, Cambridge: Cell Press, October 10, 2008, Molecular Cell, Vol. 32, pp. 11-20. DOI: 10.1016/j.molcel.2008.09.011; http://www.cell.com/molecular-cell/abstract/S1097-2765(08)00656-4?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1097276508006564%3Fshowall%3Dtrue. ISSN: 1097-2765.

  196. Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation. Dolfini, Ersilia, et al., et al. 2, s.l.: Elsevier Ireland Ltd., May 8, 2007, Cancer Letters, Vol. 249, pp. 143-147. DOI: 10.1016/j.canlet.2006.08.013; http://www.cancerletters.info/article/S0304-3835(06)00502-7/abstract. ISSN: 0304-3835.

  197. Resveratrol: A review of preclinical studies for human cancer prevention. Athar, Mohammad, et al., et al. [ed.] Michael P. Waalkes. 3, Research Triangle Park: Elsevier Inc., January 3, 2007, Toxicology and Applied Pharmacology, Vol. 224, pp. 274-283. DOI: 10.1016/j.taap.2006.12.025; http://www.sciencedirect.com/science/article/pii/S0041008X06005035. ISSN: 0041-008X.

  198. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Fukui, M., Yamabe, N., Zhu, B.T. [ed.] John Smyth. 10, Edinburgh: Elsevier Ltd., July 2010, European Journal of Cancer, Vol. 46, pp. 1882-1891. DOI: 10.1016/j.ejca.2010.02.004; http://www.ejcancer.com/article/S0959-8049(10)00107-3/abstract. ISSN: 0959-8049.

  199. Colorectal Cancer Stem Cells and Cell Death. Catalano, Veronica, et al., et al. [ed.] Robert H. Weiss. 2, Basel: MDPI AG, April 11, 2011, Cancers, Vol. 3, pp. 1929-1946. DOI: 10.3390/cancers3021929; http://www.mdpi.com/2072-6694/3/2/1929/pdf. ISSN: 2072-6694.

  200. Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (Review). Aziz, Moammir H., Kumar, Raj and Ahmad, Nihal. 1, s.l.: Spandidos Publications, July 1, 2003, International Journal of Oncology, Vol. 23, pp. 17-28. DOI: 10.3892/ijo.23.1.17; http://www.spandidos-publications.com/10.3892/ijo.23.1.17. ISSN: 1019-6439..

  201. Harvard Men's Health Watch. Red Wine Protects The Prostate, Research Suggests. ScienceDaily. [Online] May 26, 2007. [Cited: March 26, 2014.] http://www.sciencedaily.com/releases/2007/05/070525215203.htm.

  202. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Wang, Thomas T.Y., et al., et al. [ed.] Curtis C. Harris. 10, Bethesda: Oxford University Press, October 2008, Carcinogenesis, Vol. 29, pp. 2001-2010. DOI: 10.1093/carcin/bgn131; http://carcin.oxfordjournals.org/content/29/10/2001.full. ISSN: 0143-3334.

  203. Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor. Ganapathy, Suthakar, et al., et al. [ed.] Hiranmoy Das. 12, Columbus: Public Library of Science, December 28, 2010, PLoS ONE, Vol. 5, p. e15627. DOI: 10.1371/journal.pone.0015627; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015627. ISSN: 1932-6203.

  204. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Narayanan, Narayanan K., et al., et al. [ed.] Harald zur Hausen. 1, Heidelberg: John Wiley & Sons, Inc.: UICC, July 1, 2009, International Journal of Cancer, Vol. 125, pp. 1-8. DOI: 10.1002/ijc.24336; http://onlinelibrary.wiley.com/doi/10.1002/ijc.24336/abstract. ISSN: 1097-0215.

  205. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Shankar, Sharmila, Siddiqui, Imtiaz and Srivastava, Rakesh K. [ed.] Naranjan S. Dhalla. 1-2, Winnipeg: Springer Science+Business Media, October 2007, Molecular and Cellular Biochemistry, Vol. 304, pp. 273-285. DOI: 10.1007/s11010-007-9510-x; http://link.springer.com/article/10.1007%2Fs11010-007-9510-x. ISSN: 0300-8177.

  206. Carsten, Ronald E. In-vivo investigation of resveratrol as a preventive for radiation-induced acute myeloid leukemia. [ed.] Colorado State University. s.l.: ProQuest, 2008. ISBN: 1-109-01177-6.

  207. U.S. National Library of Medicine. What You Need To Know About™ Leukemia: Types of Leukemia. NIH Senior Health. [Online] [Cited: March 26, 2014.] U.S. Department of Health and Human Services. http://nihseniorhealth.gov/leukemia/whoisatrisk/01.html.

  208. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. Podhorecka, Monika, et al., et al. [ed.] Arnold Ganser. 2, Hannover: Springer-Verlag, February 2010, Annals of Hematology, Vol. 90, pp. 173-183. DOI: 10.1007/s00277-010-1045-7; http://link.springer.com/article/10.1007%2Fs00277-010-1045-7/fulltext.html. ISSN: 0939-5555.

  209. National Cancer Institute. What You Need To Know About™ Leukemia: Normal Blood Cells. National Institutes of Health. [Online] December 23, 2013. [Cited: March 26, 2014.] U.S. Department of Health and Human Services. http://www.cancer.gov/cancertopics/wyntk/leukemia/page2.

  210. —. What You Need To Know About™ Leukemia: Types of Leukemia. National Institutes of Health. [Online] December 23, 2013. [Cited: March 26, 2014.] U.S. Department of Health and Human Services. http://www.cancer.gov/cancertopics/wyntk/leukemia/page4.

  211. Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1. Niu, Xiao-Fang, et al., et al. [ed.] Christna Chap. 1, London: BioMed Central Ltd., March 19, 2011, BMC Cancer, Vol. 11, pp. 99-108. DOI: 10.1186/1471-2407-11-99; http://www.biomedcentral.com/1471-2407/11/99. ISSN: 1471-2407.

  212. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. Chakraborty, Prabir K., et al., et al. [ed.] Takashi Tsuruo. 6, Tokyo: John Wiley & Sons, Inc.: Japanese Cancer Association, June 2008, Cancer Science, Vol. 99, pp. 1109-1116. DOI: 10.1111/j.1349-7006.2008.00809.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2008.00809.x/abstract. eISSN: 1349-7006.

  213. Identification of compounds targeting human leukemia stem cells. McDermott, Sean P., et al., et al. [ed.] Napoleone Ferrara. 12, Supplement 1, Philadelphia: American Association for Cancer Research, Inc., November 16, 2009, Molecular Cancer Therapeutics, Vol. 8, p. Abstract A51. DOI: 10.1158/1535-7163.TARG-09-A51; http://mct.aacrjournals.org/cgi/content/short/8/12_MeetingAbstracts/A51. ISSN: 1535-7163.

  214. Disparate In Vitro and In Vivo Antileukemic Effects of Resveratrol, a Natural Polyphenolic Compound Found in Grapes. Gao, Xiaohua, et al., et al. [ed.] John W. Suttie. 7, Bethesda: The American Society for Nutritional Sciences, July 1, 2002, Journal of Nutrition®, Vol. 132, pp. 2076-2081. ISSN: 0022-3166.

  215. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C. Fritzer-Szekeres, Monika, et al., et al. [ed.] Demetrios A. Spandidos. 4, Athens: Spandidos Publications, October 1, 2008, International Journal of Oncology, Vol. 33, pp. 887-892. DOI: 10.3892/ijo_00000077; http://www.spandidos-publications.com/ijo/33/4/887/abstract. ISSN: 1019-6439.

  216. Cytosine arabinoside potentiates the apoptotic eff ect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines. Castegnaro, Silvia, et al., et al. [ed.] Aaron Polliack, Koen Van Besien and John Seymour. 11, Jerusalem; New York; Victoria: Informa Plc, November 2012, Leukemia & Lymphoma, Vol. 53, pp. 2262-2268. DOI: 10.3109/10428194.2012.688200; http://informahealthcare.com/doi/abs/10.3109/10428194.2012.688200. ISSN: 1042-8194.

  217. Khakoo, Aarif Y. and Kwartler, Callie S. Cardiovascular Complications of Cancer Therapeutics. [ed.] Élie Azoulay. Pulmonary Involvement in Patients with Hematological Malignancies. Berlin Heidelberg: Springer-Verlag, 2011, 9, pp. 87-116. ISBN: 978-3-642-15742-4.

  218. Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition. Shankar, Sharmila, et al., et al. [ed.] Lin Zhang. 1, Philadelphia: Public Library of Science, January 31, 2011, PLoS One, Vol. 6, p. e16530. DOI: 10.1371/journal.pone.0016530; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0016530. ISSN: 1932-6203.

  219. Angioprevention is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis. Bishayee, Anupam, Petit, Danielle M. and Samtani, Karishma. [ed.] Stewart Sell. 1, Albany: OMICS Publishing Group, September 28, 2010, Journal of Carcinogenesis & Mutagenesis, Vol. 1, pp. 1-8. DOI: 10.4172/2157-2518.1000102; http://omicsonline.org/2157-2518/2157-2518-1-102.digital/2157-2518-1-102.html. ISSN: 2157-2518.

  220. University of Pittsburgh Schools of the Health Sciences. Plant Antioxidant May Protect Against Radiation Exposure. ScienceDaily. [Online] September 24, 2008. [Cited: March 27, 2014.] http://www.sciencedaily.com/releases/2008/09/080923181110.htm.

  221. Centers for Disease Control and Prevention. Frequently Asked Questions about a Radiation Emergency: Potassium Iodide (KI). CDC Emergency Preparedness and Response. [Online] February 4, 2014. [Cited: March 8, 2014.] http://www.bt.cdc.gov/radiation/ki.asp.

  222. Preparatory Commission for the Comprehensive Nuclear Test Ban Treaty Organization. Fukushima-Related Radioactive Materials Measured Across Entire Northern Hemisphere. ScienceDaily LLC. [Online] April 7, 2011. [Cited: June 28, 2011.] http://www.sciencedaily.com/releases/2011/04/110407121343.htm.

  223. United States Environmental Protection Agency. Health Effects. U.S. EPA Radiation Protection. [Online] August 7, 2012. [Cited: March 27, 2014.] http://www.epa.gov/rpdweb00/understand/health_effects.html#whatkind.

  224. Okunieff, Paul, et al., et al. Antioxidants Reduce Consequences of Radiation Exposure. [ed.] Kyung A. Kang, David K. Harrison and Duane F. Bruley. Oxygen Transport to Tissue XXIX. New York: Springer Science+Business Media, LLC, 2008, Vol. 614, 20, pp. 165-178. ISBN: 978-0-387-74910-5.

  225. U.S. Environmental Protection Agency. 60 Co y-irradiat. U.S. EPA Radiation Protection. [Online] March 6, 2012. [Cited: March 27, 2014.] http://www.epa.gov/rpdweb00/radionuclides/cobalt.html#affecthealth.

  226. Study on radiation protective effect of resveratrol and its molecular mechanism. Lv, Qiu-jun, et al., et al. 1, Beijing: Tsinghua Tongfang Knowledge Network Technology Co., Ltd., February 2004, Chinese Journal of Radiation Mediation and Protection, Vol. 24, pp. 21-22. ISSN: 0254-5098.

  227. Protective action of peanut oil in rats exposed to gamma-rays. Edrees, G.M.F., et al., et al. 2, Bruxelles: Royal Belgian Institute of Natural Sciences, July 2008, Belgian Journal of Zoology, Vol. 138, pp. 149-153. ISSN: 0777-6276.

  228. Stein, Rob. Radiation exposure poses range of potential health problems for Japanese. The Washington Post. [Online] March 12, 2011. [Cited: March 27, 2014.] http://www.washingtonpost.com/wp-dyn/content/article/2011/03/12/AR2011031203446.html.

  229. Sharma, Pramod K. and III, Michael M Johns. Thyroid Cancer. Medscape Reference. [Online] March 10, 2014. [Cited: March 27, 2014.] WebMD LLC. http://emedicine.medscape.com/article/851968-overview#showall.

  230. Miller, Jason. Iodine/radioactive Iodine information. Hawaii Health Guide. [Online] March 24, 2011. [Cited: March 27, 2014.] http://www.hawaiihealthguide.com/healthtalk/display.htm?id=910.

  231. Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism. Shih, Ai, et al., et al. [ed.] Paul W. Ladenson. 3, Baltimore: The Endocrine Society, March 1, 2002, The Journal of Clinical Endocrinology & Metabolism, Vol. 87, pp. 1223-1232. DOI: 10.1210/jc.87.3.1223; http://press.endocrine.org/doi/abs/10.1210/jcem.87.3.8345. ISSN: 0021-972X.

  232. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Truong, Matthew, et al., et al. [ed.] Charles M. Balch. 5, Baltimore: Springer Healthcare Ltd.: The Society of Surgical Oncology, May 1, 2011, Annals of Surgical Oncology , Vol. 18, pp. 1506-1511. DOI: 10.1245/s10434-010-1488-z; http://link.springer.com/article/10.1245%2Fs10434-010-1488-z. ISSN: 1068-9265.

  233. Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5. Sebai, Hichem, et al., et al. [ed.] Charles H. Emerson. 2, Worcester: Mary Ann Liebert, Inc., February 2010, Thyroid, Vol. 20, pp. 195-203. DOI: 10.1089/thy.2009.0171; http://online.liebertpub.com/doi/abs/10.1089/thy.2009.0171. ISSN: 1050-7256.

  234. A.D.A.M. Medical Encyclopedia. Endometriosis. U.S. National Library of Medicine: National Center for Biotechnology Information. [Online] August 5, 2013. [Cited: March 27, 2014.] http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001913/.

  235. Increased Numbers of Activated Mast Cells in Endometriosis Lesions Positive for Corticotropin-Releasing Hormone and Urocortin. Kempuraj, Duraisamy, et al., et al. [ed.] Kenneth D. Beaman. 4, Oxford: Blackwell Munksgaard, October 2004, American Journal of Reproductive Immunology, Vol. 52, pp. 267-275. DOI: 10.1111/j.1600-0897.2004.00224.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0897.2004.00224.x/abstract. eISSN: 1600-0897.

  236. Klabunde, Richard E. Nitric Oxide. Cardiovascular Physiology Concepts. [Online] September 23, 2008. [Cited: March 27, 2014.] http://www.cvphysiology.com/Blood%20Flow/BF011.htm.

  237. Pistachio diet improves erectile function parameters and serum lipid profiles in patients with erectile dysfunction. Aldemir, M., et al., et al. [ed.] Nestor F. Gonzalez-Cadavid. 1, Torrance: Nature Publishing Group, January/February 2011, International Journal of Impotence Research, Vol. 23, pp. 32-38. DOI: 10.1038/ijir.2010.33; http://www.nature.com/ijir/journal/v23/n1/full/ijir201033a.html. ISSN: 0955-9930.

  238. Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis. Cui, Xiangli, et al., et al. [ed.] Scott M. Lippman. 4, Philadelphia: American Association for Cancer Research, April 2010, Cancer Prevention Research, Vol. 3, pp. 549-559. DOI: 10.1158/1940-6207.CAPR-09-0117; http://cancerpreventionresearch.aacrjournals.org/content/3/4/549.full. ISSN: 1940-6207.

  239. Innate lymphocytes induce inflammatory bowel disease. Diefenbach, Andreas and Vonarbourg, Cedric. [ed.] Chris Parish. 7, Canberra: Nature Publishing Group, October 2010, Immunology and Cell Biology, Vol. 88, pp. 694-696. DOI: 10.1038/icb.2010.82; http://www.nature.com/icb/journal/v88/n7/full/icb201082a.html. ISSN: 0818-9641.

  240. The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study. Bernstein, Charles N., Wajda, Andre and Blanchard, James F. [ed.] David A. Brenner. 3, New York: Elsevier Inc.: American Gastroenterological Association, September 2005, Gastroenterology, Vol. 129, pp. 827-836. DOI: 10.1053/j.gastro.2005.06.021; http://www.gastrojournal.org/article/S0016-5085(05)01123-6/abstract. ISSN: 0016-5085.

  241. Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation. Bereswill, Stefan, et al., et al. [ed.] Niyaz Ahmed. 12, Hyderabad: Public Library of Science, December 3, 2010, PLoS ONE, Vol. 5, p. e15099. DOI: 10.1371/journal.pone.0015099; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015099. ISSN: 1932-6203.

  242. Immunomodulation of Autoimmune Arthritis by Herbal CAM. Venkatesha, Shivaprasad H., et al., et al. [ed.] Edwin L. Cooper. Article ID 986797, New York; Cairo: Hindawi Publishing Corporation, September 30, 2010, Evidence-Based Complementary and Alternative Medicine, Vol. 2011, pp. 1-13. DOI: 10.1155/2011/986797; http://www.hindawi.com/journals/ecam/2011/986797/. ISSN: 1741-427X.

  243. Effects of Resveratrol in Inflammatory Arthritis. Elmali, N., et al., et al. 1-2, s.l.: Kluwer Academic Publishers-Plenum Publishers, April 1, 2007, Inflammation, Vol. 30, pp. 1-6. DOI: 10.1007/s10753-006-9012-0; http://link.springer.com/article/10.1007%2Fs10753-006-9012-0. ISSN: 0360-3997.

  244. Brook, Itzhak and Hinthorn, Daniel R. Chronic Sinusitis Overview and Treatment. Medscape Reference. [Online] January 28, 2014. [Cited: March 28, 2014.] WebMD LLC. http://emedicine.medscape.com/article/232791-overview#showall.

  245. Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium. Alexander, Nathan S., et al., et al. [ed.] Jonas T. Johnson. 6, Pittsburgh: John Wiley & Sons, Inc.: The American Laryngological, Rhinological and Otological Society, Inc., June 2011, The Laryngoscope, Vol. 121, pp. 1313-1319. DOI: 10.1002/lary.21798; http://onlinelibrary.wiley.com/doi/10.1002/lary.21798/abstract. ISSN: 0023-852X.

  246. Evaluation of the efficacy and safety of "Anti-Wrinkle cream" in the treatment of facial skin wrinkles: A prospective, open, phase III clinical trial. Ravichandran, G., Bharadwaj, V. Shivaram and Kolhapure, S.A. 2, 2005, The Antiseptic, Vol. 102, pp. 65-70. ISSN: 0003-5998.

  247. Assaf, Hanan, Adly, Mohamed A. and Hussein, Mahmoud R. Aging and Intrinsic Aging: Pathogenesis and Manifestations. [ed.] Miranda A. Farage, Kenneth W. Miller and Howard I. Maibach. Textbook of Aging Skin. Berlin: Springer-Verlag Berlin Heidelberg, 2010, 13, pp. 129-138. ISBN: 978-3-540-89655-5.

  248. Thompson, Zack and Maibach, Howard I. Biological Effects of Estrogen on Skin. [ed.] Miranda A. Farage, Kenneth W. Miller and Howard I. Maibach. Textbook of Aging Skin. Berlin: Springer-Verlag Berlin Heidelberg, 2010, 35, pp. 361-368. ISBN: 978-3-540-89655-5.

  249. Baumann, Leslie. Cosmeceutical Critque: Sirtuins. Skin Type Solutions. [Online] 2011. [Cited: March 29, 2014.] http://www.skintypesolutions.com/index.php?option=com_article&view=article&id=219.

  250. —. Nutrition and the Skin. [ed.] Leslie Baumann, Sogol Saghari and Edmund Weisberg. Cosmetic Dermatology Principles and Practice. 2nd. New York: The McGraw-Hill Companies, Inc., 2009, 8, pp. 45-68. ISBN: 978-0-07-164128-9.

  251. Cosmeceutical Agents: A Comprehensive Review of the Literature. Tsai, Thomas C. and Hantash, Basil M. [ed.] Robert Pearl. 1, London: Libertas Academica, January 2008, Clinical Medicine Insights: Dermatology, Vol. 2008, pp. 1-20. ISSN: 1179-5492.

  252. Rao, Smitha, et al., et al. Fusion Technology: The Microbial Fermentation of Small Molecules for Skin Care. Arch Personal Care Products, L.P.; BioInnovation Laboratories. s.l.: Cosmetic Science Technology, 2009. pp. 84-91, White Paper.

  253. Wolff, Klaus and Johnson, Richard Allen. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 6. New York: The McGraw-Hill Companies, Inc., 2009. ISBN: 978-0-07-163342-0.
  254. Kindred, Chesahna and Halder, Rebat M. Pigmentation and skin of color. [ed.] Zoe Diana Draelos. Cosmetic Dermatology: Products and Procedures. West Sussex: Blackwell Publishing Ltd, 2010, 4, pp. 27-37. ISBN: 978-1-4051-8635-3.

  255. The melanogenesis and mechanisms of skin-lightening agents - existing and new approaches. Gillbro, J. M. and Olsson, M. J. [ed.] Anthony Rawlings. 3, s.l.: John Wiley & Sons, Inc.: Society of Cosmetic Scientists and the Société Française de Cosmétologie, June 2011, International Journal of Cosmetic Science, Vol. 33, pp. 210-221. DOI: 10.1111/j.1468-2494.2010.00616.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1468-2494.2010.00616.x/full. eISSN: 1468-2494.

  256. Baumann, Leslie and Allemann, Inja Bogdan. Depigmenting Agents. [ed.] Leslie Baumann, Sogol Saghari and Edmund Weisberg. Cosmetic Dermatology Principles and Practice. New York: The McGraw-Hill Companies, Inc., 2009, 33, pp. 279-291. ISBN: 978-0-07-164128-9.

  257. Post-Transcriptional Regulation of Melanin Biosynthetic Enzymes by cAMP and Resveratrol in Human Melanocytes. Newton, Richard A., et al., et al. [ed.] Lowell A. Goldsmith. 9, Chapel Hill: Nature Publishing Group, April 26, 2007, Journal of Investigative Dermatology, Vol. 127, pp. 2216-2227. DOI: 10.1038/sj.jid.5700840; http://www.nature.com/jid/journal/v127/n9/full/5700840a.html. ISSN: 0022-202X.

  258. A newly synthesized, potent tyrosinase inhibitor: 5-(6-Hydroxy-2-naphthyl)-1,2,3-benzenetriol. Choi, Jehun, et al., et al. [ed.] D.L. Boger. 16, La Jolla: Elsevier Ltd., August 15, 2010, Bioorganic & Medicinal Chemistry Letters, Vol. 20, pp. 4882-4884. DOI: 10.1016/j.bmcl.2010.06.087; http://www.sciencedirect.com/science/article/pii/S0960894X10008619. ISSN: 0960-894X.

  259. Modulation of Microphthalmia-associated Transcription Factor Gene Expression Alters Skin Pigmentation. Lin, C.B., et al., et al. [ed.] Lowell A. Goldsmith. 6, Chapel Hill: Nature Publishing Group, December 2002, Journal of Investigative Dermatology, Vol. 119, pp. 1330-1340. DOI: 10.1046/j.1523-1747.2002.19615.x; http://www.nature.com/jid/journal/v119/n6/full/5603342a.html. ISSN: 0022-202X.

  260. Center for New Crops & Plants Products. NewCROPTM: Breadfruit. Purdue University. [Online] [Cited: March 29, 2014.] https://www.hort.purdue.edu/newcrop/morton/breadfruit.html..

  261. The Hunt for Natural Skin Whitening Agents. Smit, Nico, Vicanova, Jana and Pavel, Stan. [ed.] Michael N. Hall. 12, Basel: MDPI AG, December 10, 2009, International Journal of Molecular Sciences, Vol. 10, pp. 5326-5349. DOI: 10.3390/ijms10125326; http://www.mdpi.com/1422-0067/10/12/5326/pdf. ISSN: 1422-0067.

  262. Artocarpus lakoocha heartwood extract as a novel cosmetic ingredient: evaluation of the in vitro anti-tyrosinase and in vivo skin whitening activities. Tengamnuay, P., et al., et al. [ed.] Anthony Rawlings. 4, London: John Wiley & Sons, Inc.: Society of Cosmetic Scientists and the Société Française de Cosmétologie, August 2006, International Journal of Cosmetic Science, Vol. 28, pp. 269-276. DOI: 10.1111/j.1467-2494.2006.00339.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1467-2494.2006.00339.x/abstract. eISSN: 1468-2494.

  263. An Updated Review of Tyrosinase Inhibitors. Chan, Te-Sheng. [ed.] Michael N. Hall. 6, Basel: MDPI AG, May 26, 2009, International Journal of Molecular Sciences, Vol. 10, pp. 2440-2475. DOI: 10.3390/ijms10062440; http://www.mdpi.com/1422-0067/10/6/2440/pdf. ISSN: 1422-0067.

  264. Stilbenes with tyrosinase inhibitory activity. Likhitwitayawuid, Kittisak. [ed.] Padmanabhan Balaram. 1, Bangalore: Indian Academy of Sciences, January 10, 2008, Current Science, Vol. 94, pp. 44-52. ISSN: 0011-3891.

  265. Brown, David. Is Lincoln Earliest Recorded Case of Rare Disease? The Washington Post. [Online] November 26, 2007. [Cited: March 29, 2014.] http://www.washingtonpost.com/wp-dyn/content/story/2007/11/26/ST2007112600664.html.

  266. Radiation Studies Branch (RSB), Division of Environmental Hazards and Health Effects (EHHE), National Center for Environmental Health (NCEH), Coordinating Center for Environmental Health and Injury Prevention (CCEHIP). Potassium Iodide (KI). CDC Emergency Preparedness and Response. [Online] February 4, 2014. [Cited: March 29, 2014.] http://www.bt.cdc.gov/radiation/ki.asp.

  267. Karim, M.Y. Diseases and conditions: Eosinophilia. NetDoctor. [Online] February 6, 2005. [Cited: March 29, 2014.] http://www.netdoctor.co.uk/diseases/facts/eosinophilia.htm.

  268. Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology. Leung, Maxwell C. K., et al., et al. [ed.] Lois Lehman-McKeeman. 1, Princeton: Oxford University Press: Society of Toxicology, November 2008, Toxicological Sciences, Vol. 106, pp. 5-28. DOI: 10.1093/toxsci/kfn121http://toxsci.oxfordjournals.org/content/106/1/5.long. ISSN: 1096-6080.

  269. Wellcome Trust Sanger Institute. Annual Report and Financial Accounts. Wellcome Trust. [Online] 2010. [Cited: March 29, 2014.] http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_publishing_group/documents/web_document/wtx063982.pdf.

  270. Aronson, J.K. Meyler's Side Effects of Herbal Medicines. Amsterdam: Elsevier B.V., 2009. ISBN: 978-044-453269-5.

  271. Therapeutic Research Faculty. Vetiveria zizanioides Monograph. Natural Medicines Comprehensive Database. [Online] March 28, 2014. [Cited: March 29, 2014.] http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?pt=100&id=695.

  272. —. White Sandalwood Monograph. Natural Medicines Comprehensive Database. [Online] March 28, 2014. [Cited: March 29, 2014.] http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?pt=100&id=116.

  273. —. Costus Monograph. Natural Medicines Comprehensive Database. [Online] March 28, 2014. [Cited: March 29, 2014.] http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?pt=100&id=855.

  274. Antioxidant and hypolipidemic activity of Kumbhajatu in hypercholesterolemic rats. Ghosh, Rumi, Kadam, Parag P. and Kadam, Vilasrao J. [ed.] Urmila Thatte. 3, Mumbai: Medknow Publications, Jul-Sep 2010, International Journal of Ayurveda Research, Vol. 1, pp. 159-162. DOI: 10.4103/0974-7788.72487; http://www.ijaronline.com/text.asp?2010/1/3/159/72487. ISSN: 0974-7788.

  275. Caldecott, Todd. Ayurveda: The Divine Science of Life. s.l.: Elsevier Health Sciences, 2006. ISBN: 978-0-7234-3410-8.

  276. Tirtha, Swami Sadashiva. The Ãyurveda Encyclopedia: Natural Secrets to Healing, Prevention & Longevity. Bayville: Ayurveda Holistic Center Press, 2005. ISBN: 0-9658042-2-4.

  277. Development of a Lozenge for Oral Transmucosal Delivery of Trans-Resveratrol in Humans: Proof of Concept. Blanchard, Otis L., et al., et al. [ed.] Joseph J. Barchi. 2, Frederick: Public Library of Science, February 26, 2014, PLoS ONE, Vol. 9, p. e90131. DOI: 10.1371/journal.pone.0090131; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090131. eISSN: 1932-6203.